This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astrazeneca Ab. Active years: 2010-2013.
Company Filing History:
Years Active: 2010-2013
Title: Rhony Aufdenblatten: Innovator in Pharmaceutical Chemistry
Introduction
Rhony Aufdenblatten is a notable inventor based in Visp, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of three patents. His work focuses on innovative processes that enhance the preparation of complex chemical compounds.
Latest Patents
Among his latest patents, one invention is directed to a process for preparing a specific compound, which includes [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol. This invention also details intermediates that are useful in the process. Another patent involves a process and catalyst for the catalytic hydrogenation of aromatic or heteroaromatic nitro compounds to their corresponding amines. This process utilizes a platinum catalyst modified with a molybdenum compound and a phosphorus compound, particularly effective for nitro compounds with halogen and/or sulfur-containing substituents.
Career Highlights
Rhony Aufdenblatten is currently associated with AstraZeneca AB, where he applies his expertise in pharmaceutical development. His innovative approaches have contributed to advancements in drug formulation and synthesis.
Collaborations
He has collaborated with notable colleagues, including Martin Hans Bohlin and Helena Hellström, enhancing the collaborative spirit within his research environment.
Conclusion
Rhony Aufdenblatten's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in drug development and synthesis.